Targeted Delivery of CD34 Aptamer-Coupled Tocilizumab Microspheres for Effective Treatment of Thyroid-Associated Ophthalmopathy. [PDF]
Luo Y +8 more
europepmc +1 more source
Machine learning unveils hypoxia-immune gene hub for clinical stratification of thyroid-associated ophthalmopathy. [PDF]
Chen L +5 more
europepmc +1 more source
Application of protein A immunoadsorption in thyroid-associated ophthalmopathy (TAO): study protocol for a non-randomised controlled clinical trial. [PDF]
Lu S, Chen H, Liu S, Zhang F, Xiong W.
europepmc +1 more source
Percutaneous para-levator palpebrae superioris and subconjunctival injection of triamcinolone acetonide for upper eyelid retraction in thyroid-associated ophthalmopathy. [PDF]
Wang M, Luan Y, Qian Z, Wang Y, Fang W.
europepmc +1 more source
LSD1 induces H3 K9 demethylation to promote adipogenesis in thyroid-associated ophthalmopathy. [PDF]
Xu Y +9 more
europepmc +1 more source
Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy. [PDF]
Zhu XY, Zhou WY, Li T.
europepmc +1 more source
Orbital computed tomography imaging characteristics of thyroid-associated ophthalmopathy. [PDF]
Xiong C +7 more
europepmc +1 more source
Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy. [PDF]
Huang Z, Xu M, Zhang W, Song X.
europepmc +1 more source
Quantitative analysis of orbital soft tissue for the detection of dysthyroid optic neuropathy in patients with thyroid-associated ophthalmopathy, based on three-dimensional cube fast spin-echo Flex. [PDF]
Liang W +9 more
europepmc +1 more source
Thyroid-associated ophthalmopathy and ferroptosis: a review of pathological mechanisms and therapeutic strategies. [PDF]
Ma C, Li H, Lu S, Li X.
europepmc +1 more source

